Integer Holdings (ITGR) Cost of Revenue (2010 - 2026)
Integer Holdings (ITGR) reported Cost of Revenue of $330.0 million for Q2 2026, up 4.07% on a YoY basis from $317.1 million in Q2 2025, and down 4.99% sequentially from $347.3 million in Q4 2025.
Integer Holdings (ITGR) Cost of Revenue (2010 - 2026) Analysis & Trends
Integer Holdings (ITGR) has 17 years of Cost of Revenue data on file, last reported at $330.0 million in Q2 2026.
- For the quarter ending Q2 2026, Cost of Revenue rose 4.07% year-over-year to $330.0 million; the trailing twelve-month figure through Apr 2026 stood at $1.4 billion (up 7.14% YoY), and the FY2025 full-year result was $1.4 billion, up 7.61% from the prior year.
- Cost of Revenue retreated to $330.0 million in Q2 2026, from $347.3 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $347.3 million in Q2 2025 to a low of $229.4 million in Q2 2022.
- A 5-year average of $299.4 million and a median of $299.5 million in 2024 frame the typical range for Cost of Revenue.
- Across the five-year window, Cost of Revenue increased 22.96% in 2023 and advanced 4.07% in 2026, its largest moves.
- Tracing ITGR's Cost of Revenue over 5 years: stood at $242.9 million in 2022, then climbed by 21.41% to $294.9 million in 2023, then increased by 12.8% to $332.7 million in 2024, then gained by 4.39% to $347.3 million in 2025, then decreased by 4.99% to $330.0 million in 2026.
- Business Quant data shows ITGR's Cost of Revenue at $330.0 million in Q2 2026, $347.3 million in Q4 2025, and $341.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 4.89 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.21 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 12.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 362.60 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 441.60 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 481.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2.51 Bn |
| 10 | Integer Holdings | 3.40 Bn | 3.40 Bn | 109.60 Mn | 329.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 329.99 Mn |
| Apr 3, 2026 | 329.99 Mn |
| Dec 31, 2025 | 347.30 Mn |
| Dec 31, 2025 | 347.30 Mn |
| Sep 26, 2025 | 341.53 Mn |
| Sep 26, 2025 | 341.53 Mn |
| Jun 27, 2025 | 347.34 Mn |
| Jun 27, 2025 | 347.34 Mn |
| Mar 28, 2025 | 317.07 Mn |
| Mar 28, 2025 | 317.07 Mn |
| Dec 31, 2024 | 332.70 Mn |
| Dec 31, 2024 | 332.70 Mn |
| Sep 27, 2024 | 314.85 Mn |
| Sep 27, 2024 | 314.85 Mn |
| Jun 28, 2024 | 310.51 Mn |
| Jun 28, 2024 | 310.51 Mn |
| Mar 29, 2024 | 299.52 Mn |
| Mar 29, 2024 | 299.52 Mn |
| Dec 31, 2023 | 294.94 Mn |
| Dec 31, 2023 | 294.94 Mn |